MARKET

FBIO

FBIO

Fortress Biotech Inc
NASDAQ
3.340
+0.210
+6.71%
After Hours: 3.303 -0.037 -1.12% 19:07 03/06 EST
OPEN
3.050
PREV CLOSE
3.130
HIGH
3.469
LOW
3.016
VOLUME
706.84K
TURNOVER
--
52 WEEK HIGH
4.530
52 WEEK LOW
1.325
MARKET CAP
103.67M
P/E (TTM)
-11.3993
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at FBIO last week (0223-0227)?
Weekly Report · 5d ago
Fortress Biotech Price Target Maintained With a $17.00/Share by HC Wainwright & Co.
Dow Jones · 02/23 16:15
HC Wainwright & Co. Reiterates Buy on Fortress Biotech, Maintains $17 Price Target
Benzinga · 02/23 16:05
Fortress Biotech: PRV Windfall and De-Risked Zycubo Economics Support Buy Rating and $17 Target
TipRanks · 02/23 15:05
Fortress Biotech Rises on $205M Priority Review Voucher Sale
Dow Jones · 02/23 14:50
Cyprium Therapeutics Agrees to Sell Priority Review Voucher for $205 Million
Reuters · 02/23 14:28
UPDATE: FORTRESS BIOTECH’S SUBSIDIARY CYPRIUM THERAPEUTICS ENTERS INTO AGREEMENT TO SELL RARE PEDIATRIC DISEASE PRIORITY REVIEW VOUCHER FOR $205 MILLION
Reuters · 02/23 14:24
Cyprium Voucher Sale Bolsters Fortress Biotech Liquidity
TipRanks · 02/23 14:08
More
About FBIO
Fortress Biotech, Inc. is a biopharmaceutical company focused on acquiring and advancing assets. The Company has eight marketed prescription pharmaceutical products and over 20 programs in development, with its majority-owned and majority-controlled partners and subsidiaries and partners and subsidiaries it founded and in which it holds significant minority ownership positions. Its portfolio is being commercialized and developed for various therapeutic areas, including oncology, dermatology, and rare diseases. Its dermatology products include Emrosi, Qbrexza, Amzeeq, Zilxi, Exelderm, Targadox, and Luxamend. Its late-stage product candidates include CUTX-101 (copper histidinate injection for Menkes disease), Triplex (cytomegalovirus (CMV) vaccine), and CAEL-101 (monoclonal antibody for AL amyloidosis). Its early and mid-stage product candidates include Dotinurad (urate transporter (URAT1) inhibitor for gout), MB-101 (IL13Rα2 CAR T Cell Program for Glioblastoma), and others.

Webull offers Fortress Biotech Inc stock information, including NASDAQ: FBIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FBIO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading FBIO stock methods without spending real money on the virtual paper trading platform.